Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy

Abnormal metabolism is another cancer hallmark. The two most characterized altered metabolic pathways are high rates of glycolysis and glutaminolysis, which are natural targets for cancer therapy. Currently, a number of newer compounds to block glycolysis and glutaminolysis are being developed; neve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervantes-Madrid, Diana, Romero, Yair, Dueñas-González, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575731/
https://www.ncbi.nlm.nih.gov/pubmed/26425550
http://dx.doi.org/10.1155/2015/690492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575731/
https://www.ncbi.nlm.nih.gov/pubmed/26425550
http://dx.doi.org/10.1155/2015/690492

Ejemplares similares